Kite Pharma just received FDA approved for a cell therapy product to treat adults with relapsed or refractory non-hodgkin lymphoma.
http://www.onclive.com/web-exclusives/fda-approves-axicabtagene-ciloleucel-for-nonhodgkin-lymphoma
Gilead Purchased Kite Pharma for $11.9B a couple of months ago.
https://www.cnbc.com/2017/08/28/gil...a-for-about-11-billion-in-cash-dow-jones.html
Just highlighting the activity in the cell therapy space for products and leaders in their field.
Cell Therapy News/Articles, page-2
-
- There are more pages in this discussion • 365 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.68 |
Change
0.175(11.6%) |
Mkt cap ! $1.113B | |||
| Open | High | Low | Value | Volume |
| $1.52 | $1.68 | $1.50 | $11.51M | 7.093M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 54716 | $1.68 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.68 | 98045 | 6 |
View Market Depth
| Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |
